Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Renata Rudelli"'
Publikováno v:
European psychiatry (Ed. Española). 8:155-162
ResumenSe trató a 24 pacientes ambulatorios esquizofrénicos crónicos con una edad media de 37,21 años ± 9,96 DT con risperidona (RSP) en una dosis de 2-9 mg/día (media = 4,46 mg/día ± 1,30 DT, media = 0,06 mg/kg ± 0,01 DT) durante un año.La
Autor:
Lorenzo Mapelli, Antonella Bitetto, Renata Rudelli, Massimo C. Mauri, L. Boscati, Marta E. Scalvini, V. Laini
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 3:115-119
Depressive disorders can be regarded as recurrent and chronic conditions that may reduce the quality of life and work output of patients. Data on the long-term efficacy of paroxetine appear to indicate that it is an effective maintenance treatment. O
Autor:
Renata Rudelli, E. Giuliani, R. Orlandi, A. Guerrini, S. Gianetti, Giordano Invernizzi, Massimo C. Mauri, Bravin S
Publikováno v:
Psychopharmacology. 137:341-344
A possible relationship between haematological adverse reactions and clozapine (CLZ) metabolism rate was studied. Sixteen chronic schizophrenic outpatients (mean age 34.62 years +/- 7.56 SD) were treated with CLZ, 75-600 mg/daily for 9 weeks. CLZ and
Publikováno v:
Drug Safety. 14:288-298
Sulpiride is a substituted benzamide with a selective action on receptors of the dopamine D2-like family, and clinical and pharmacological data suggest that it could be considered to be an atypical antipsychotic. Sulpiride penetrates the blood-brain
Autor:
Aldo Sicaro, Alberto E. Panerai, G. Panza, Massimo C. Mauri, Stefano Vanni, Daniele Audisio, Renata Rudelli, Paola Sacerdote
Publikováno v:
Psychiatry research. 78(1-2)
Cholecystokinin (CCK), β-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric
Autor:
Gaetano Penati, Elena Somaschini, Lucia Roncoroni, Matteo Longhini, Mario Mantero, Raffaele Papa, Renata Rudelli, Massimo C. Mauri
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 20(2)
1. Eating disorders can be found in several psychiatric pathologies: schizophrenia, delusional disorder (somatic type), bipolar disorders, major depressive disorder, borderline personality disorder, generalized anxiety disorder, body dysmorphic disor